Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLIF.L Regulatory News (GLIF)

  • There is currently no data for GLIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NAV Update for the quarter ended 31 March 2011

23 May 2011 10:00

RNS Number : 0765H
Greenwich Loan Income Fund Ltd
23 May 2011
 



23 May 2011

 

Greenwich Loan Income Fund Limited

 

NAV Update for the quarter ended 31 March 2011

 

Greenwich Loan Income Fund Limited ("GLIF" or "the Company") announces that as at 31 March 2011, its unaudited net asset value (NAV) per share was 70.3p. This compares to the final reported NAV of 79.2p per share as at 31 December 2010.

 

The weighted average market bid for the Company's investment portfolio at the quarter end was 95.5% of par, and for the liabilities, 85.2%. This compares to last quarter's figures of 93.4% of par and 82.2% respectively. The change in NAV resulted from the issuance of shares below NAV per share in connection with the acquisition of AMIC PLC, as well as the somewhat larger upward movement in the fair value of liabilities compared to portfolio assets. There was also a slight offset to these factors resulting from the modest strengthening of the GBP against the US dollar from year-end to 31 March.

 

As previously described to shareholders, under International Financial Reporting Standards (IFRS), the consolidated results of operations for the Company include the impact of carrying its investments and its liabilities at fair value. Shareholders should be aware that the Company's realisation of the full NAV is unlikely. The NAV, as calculated in accordance with IFRS, reflects the theoretical fair value of the liabilities of the CLO but, because the market is rather illiquid, it may be difficult for the Company to acquire any or a significant portion of those liabilities.

 

It should also be noted, as announced on 27 April 2011, that the Company is reviewing its exposure to T2 CLO I Ltd ("the CLO"), and were the CLO to no longer be consolidated in the future, the Company would carry its interest in CLO paper at fair value as determined by the Board of Directors. The Company expects that the resultant carrying value would be less than the proportionate share of NAV represented by the retained CLO interest as currently calculated under IFRS because it would no longer reflect the marking to market of liabilities below par. As a result, the net asset value determined post-deconsolidation of the CLO should be more comparable to other listed loan-focused investment companies.

 

The other two values customarily calculated to provide further clarity as to the dynamics within the value of the business are as follows:

 

- the value based upon assets at market value and liabilities at par was 50.2p per share as at 31 March 2011, compared to 45.4p per share as at 31 December 2010.

 

- the value based upon CLO assets as calculated for interest diversion purposes, remaining assets at market, and liabilities at par was 54.0p per share as at 31 March 2011, compared to 52.8p as at 31 December 2010.

 

The portfolio statistics on the Company's website (www.glifund.com) have been updated to include the most recent quarter. The CLO portfolio continues to increase in credit quality (as measured by the weighted average rating test) over the past year, whilst the weighted average spread (not taking into account LIBOR floors) has also increased. One major trend within the portfolio has been the increasing level of prepayments, averaging approximately 10% per quarter for the past year. During this period, the Company's investment manager has been able to deploy the capital successfully and in a manner consistent with the Company's investment objectives.

 

 

Contacts:

 

Geoffrey Miller

Greenwich Loan Income Fund Limited

+353 1 4433 466

 

Patrick Conroy

Greenwich Loan Income Fund Limited

+1 203 983 5282

 

Philip Secrett

Nominated Adviser

Grant Thornton Corporate Finance

+44 207 383 5100

 

James Maxwell

Singer Capital Markets Limited

+44 (0) 20 3205 7622

 

Ed Gascoigne Pees

Financial Dynamics

+44 (0) 207 269 7132

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVGIGDUCSDBGBX
Date   Source Headline
23rd Sep 20147:00 amRNSHalf Yearly Report
19th Sep 20142:55 pmRNSSharedealing
17th Sep 20147:00 amRNSAdditional Listing
16th Sep 20147:00 amRNSEmma Stubbs appointment
5th Sep 20147:00 amRNSNotice of Results
18th Aug 20147:00 amRNSNAV and Trading Update
16th Jul 20147:00 amRNS2014 Second Interim Dividend
20th Jun 20145:25 pmRNSHolding(s) in Company
20th Jun 20147:00 amRNSDirector/PDMR Shareholding
19th Jun 20147:00 amRNSAdditional Listing
12th Jun 20147:00 amRNSDisposal of CLO investments
19th May 20147:00 amRNSAgreement to Dispose of CLO investments
6th May 20147:01 amRNSDirector/PDMR Shareholding
2nd May 20145:00 pmRNSDirector/PDMR Shareholding
30th Apr 20144:56 pmRNSResult of AGM
30th Apr 20147:00 amRNSAGM Statement
24th Apr 20147:00 amRNSDividend Declaration
24th Apr 20147:00 amRNSNet Asset Value(s)
4th Apr 20143:16 pmRNSAnnual Financial Report
26th Mar 20147:00 amRNSFinal Results
24th Mar 20147:00 amRNSNotice of Results
20th Mar 20141:48 pmRNSDirector/PDMR Shareholding
19th Mar 201412:51 pmRNSAdditional Listing
6th Mar 20147:00 amRNS2013 Fourth Interim Dividend - Timetable amendment
26th Feb 201412:11 pmRNSHolding(s) in Company
19th Feb 20141:29 pmRNSHolding(s) in Company
29th Jan 201411:34 amRNSHolding(s) in Company
24th Jan 20144:45 pmRNSDirector/PDMR Shareholding
24th Jan 201412:00 pmRNSDirector/PDMR Shareholding
22nd Jan 201412:10 pmRNSDirector/PDMR Shareholding
22nd Jan 20147:00 amRNSNAV and Trading Update
21st Jan 20147:00 amRNSDividend Declaration
9th Dec 201312:46 pmRNSCancellation of listing from CISX
5th Dec 201311:30 amRNSResult of EGM
5th Dec 20138:00 amRNSDirector/PDMR Shareholding
4th Dec 20133:00 pmRNSSCRIP DIVIDEND - ADDITIONAL LISTING
13th Nov 201311:00 amRNSInvesting policy / Cancellation CISX listing / EGM
6th Nov 201311:00 amRNSHolding(s) in Company
4th Nov 20132:00 pmRNSHolding(s) in Company
29th Oct 20134:30 pmRNSHolding(s) in Company
29th Oct 20134:00 pmRNSChange of Adviser
24th Oct 20137:00 amRNSNAV and Trading Update
21st Oct 201312:45 pmRNSResult of EGM
9th Oct 20137:00 amRNSDividend Declaration
3rd Oct 201311:30 amRNSPublication of circular and General Meeting
1st Oct 20137:00 amRNSResults of Placing
30th Sep 20138:01 amRNSIssue of Equity
30th Sep 20137:00 amRNSInterim Results
24th Sep 20132:00 pmRNSHolding(s) in Company
19th Sep 20133:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.